Tudor Dialysis in Anchorage, Alaska - Dialysis Center

Tudor Dialysis is a medicare approved dialysis facility center in Anchorage, Alaska and it has 7 dialysis stations. It is located in Anchorage county at 2735 E Tudor Rd, Anchorage, AK, 99507. You can reach out to the office of Tudor Dialysis at (907) 562-1546. This dialysis clinic is managed and/or owned by Fresenius Medical Care. Tudor Dialysis has the following ownership type - Profit. It was first certified by medicare in June, 2016. The medicare id for this facility is 022510 and it accepts patients under medicare ESRD program.

Name	Tudor Dialysis
Location	2735 E Tudor Rd, Anchorage, Alaska
No. of Dialysis Stations	7
Medicare ID	022510
Managed By	Fresenius Medical Care
Ownership Type	Profit
Late Shifts	No

Dialysis Facilities may have multiple NPI numbers. We have found possible NPI number/s associated with Tudor Dialysis from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.

NPI Number	1639554017
Organization Name	Tudor Dialysis
Doing Business As	Muldoon Development Partners Llc
Address	2735 E Tudor Rd Anchorage, Alaska, 99507
Phone Number	(907) 562-1546

Dialysis patients with Hemoglobin data

9

Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.

• Hemodialysis

  Adult patients getting regular hemodialysis at the center	17
  Adult patient months included in Kt/V greater than or equal to 1.2	103
  Percentage of adult patients getting regular hemodialysis at the center	97
  Percentage of pediatric patients getting regular hemodialysis at the center

An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Tudor Dialysis with elevated calcium levels.

Patients with hypercalcemia	18
Hypercalcemia patient months	109
Hypercalcemia patients with serumcalcium greater than 10.2 mg	1
Patients with Serumphosphor	25
Patients with Serumphosphor less than 3.5 mg/dL	7
Patients with Serumphosphor from 3.5 to 4.5 mg/dL	27
Patients with Serumphosphor from 4.6 to 5.5 mg/dL	22
Patients with Serumphosphor from 5.6 to 7 mg/dL	25
Patients with Serumphosphor greater than 7 mg/dL	18

The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.

Patients included in arterial venous fistula and catheter summaries	29
Patient months included in arterial venous fistula and catheter summaries	116
Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment	71
Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer	20

The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.

Standard Hospitalization Summary Ratio(SHR) Year	January, 2016 - December, 2016
Patients in facility's Hospitalization Summary	6
Hospitalization Rate in facility	(Not Available)
Hospitalization Rate: Upper Confidence Limit
Hospitalization Rate: Lower Confidence Limit